Cargando…
Pyrrolotriazinone as an Underexplored Scaffold in Drug Discovery
Heterocyclic amino derivatives have been extensively synthesized and validated as potent bioactive compounds, and nowadays, numerous marketed drugs share these scaffolds, from very simple structures (monoamino, monocyclic compounds) to much more complex molecules (polycyclic derivatives with two or...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705011/ https://www.ncbi.nlm.nih.gov/pubmed/34959675 http://dx.doi.org/10.3390/ph14121275 |
_version_ | 1784621842385862656 |
---|---|
author | Ge, Tony Cintrat, Jean-Christophe |
author_facet | Ge, Tony Cintrat, Jean-Christophe |
author_sort | Ge, Tony |
collection | PubMed |
description | Heterocyclic amino derivatives have been extensively synthesized and validated as potent bioactive compounds, and nowadays, numerous marketed drugs share these scaffolds, from very simple structures (monoamino, monocyclic compounds) to much more complex molecules (polycyclic derivatives with two or more nitrogen atoms within the (fused) rings). In a constant quest for new chemical entities in drug discovery, a few novel heterocycles have emerged in recent years as promising building blocks for the obtainment of bioactive modulators. In this context, pyrrolotriazinones have attracted attention, and some show promising biological activities. Here, we offer an extensive review of pyrrolo[2,1-f][1,2,4]triazin-4(1H)-one and pyrrolo[1,2-d][1,2,4]triazin-4(3H)-one, describing their biological properties en route to drug discovery. |
format | Online Article Text |
id | pubmed-8705011 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87050112021-12-25 Pyrrolotriazinone as an Underexplored Scaffold in Drug Discovery Ge, Tony Cintrat, Jean-Christophe Pharmaceuticals (Basel) Review Heterocyclic amino derivatives have been extensively synthesized and validated as potent bioactive compounds, and nowadays, numerous marketed drugs share these scaffolds, from very simple structures (monoamino, monocyclic compounds) to much more complex molecules (polycyclic derivatives with two or more nitrogen atoms within the (fused) rings). In a constant quest for new chemical entities in drug discovery, a few novel heterocycles have emerged in recent years as promising building blocks for the obtainment of bioactive modulators. In this context, pyrrolotriazinones have attracted attention, and some show promising biological activities. Here, we offer an extensive review of pyrrolo[2,1-f][1,2,4]triazin-4(1H)-one and pyrrolo[1,2-d][1,2,4]triazin-4(3H)-one, describing their biological properties en route to drug discovery. MDPI 2021-12-06 /pmc/articles/PMC8705011/ /pubmed/34959675 http://dx.doi.org/10.3390/ph14121275 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Ge, Tony Cintrat, Jean-Christophe Pyrrolotriazinone as an Underexplored Scaffold in Drug Discovery |
title | Pyrrolotriazinone as an Underexplored Scaffold in Drug Discovery |
title_full | Pyrrolotriazinone as an Underexplored Scaffold in Drug Discovery |
title_fullStr | Pyrrolotriazinone as an Underexplored Scaffold in Drug Discovery |
title_full_unstemmed | Pyrrolotriazinone as an Underexplored Scaffold in Drug Discovery |
title_short | Pyrrolotriazinone as an Underexplored Scaffold in Drug Discovery |
title_sort | pyrrolotriazinone as an underexplored scaffold in drug discovery |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705011/ https://www.ncbi.nlm.nih.gov/pubmed/34959675 http://dx.doi.org/10.3390/ph14121275 |
work_keys_str_mv | AT getony pyrrolotriazinoneasanunderexploredscaffoldindrugdiscovery AT cintratjeanchristophe pyrrolotriazinoneasanunderexploredscaffoldindrugdiscovery |